Related Experiment Videos
Growth factor biology and oncogene activation in human gliomas and their implications for specific therapeutic
1Department of Neurological Surgery, University Hospital of Eppendorf, Hamburg, Federal Republic of Germany.
Abstract:
The failure of most available treatment modalities to improve the survival time and the quality of survival in patients with gliomas calls for the intense biological analysis of glial neoplasia. The untimely activation of cellular protooncogenes is often related to the process of neoplasia. Several protein growth factors as well as their cellular receptors have been identified as products of proto-oncogenes. Furthermore, these growth factors have been identified as glial mitogens in normal glial cell cultures as well as in tumors. The analysis of growth factor biology gains additional weight by the demonstration of autocrine growth factor secretion by tumor cells. The role of epidermal growth factor (EGF) and its receptor system in glial cell proliferation and differentiation is presented, with the speculation that the EGF receptor system may integrate the biological actions of many different factors, of which EGF itself may be least important. The literature on platelet-derived growth factor and insulin-like growth factors is reviewed, and the biology of fibroblast growth factor is presented in perspective with such phenomena as neovascularization and cell-matrix interactions.
Insights
Glioma treatments are insufficient, prompting research into glial neoplasia biology. Proto-oncogene activation and growth factors like EGF are key to tumor growth, highlighting potential new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Gliomas have poor prognoses despite current treatments, necessitating deeper biological understanding.
- Neoplasia is linked to the premature activation of cellular proto-oncogenes.
- Proto-oncogenes encode protein growth factors and receptors crucial for cell growth.
Purpose of the Study:
- To analyze the biological mechanisms underlying glial neoplasia.
- To review the role of growth factors and their receptors in glioma development.
- To explore potential therapeutic targets based on growth factor signaling.
Main Methods:
- Literature review of growth factor biology in glial tumors.
- Analysis of epidermal growth factor (EGF) and its receptor system.
- Examination of platelet-derived growth factor (PDGF), insulin-like growth factors (IGFs), and fibroblast growth factor (FGF).
Main Results:
- Growth factors act as glial mitogens in normal and tumor cells.
- Tumor cells can exhibit autocrine growth factor secretion.
- The EGF receptor system may integrate multiple signaling pathways, with EGF potentially being less critical than other factors.
Conclusions:
- Understanding growth factor signaling is crucial for glioma research.
- Targeting growth factor pathways offers potential for novel glioma therapies.
- Further investigation into EGF receptor interactions and other growth factors like FGF is warranted.